Keyphrases
Mesenchymal Stem Cells
100%
Exosomes
42%
Preeclampsia
41%
Gelatin
28%
Mesenchymal Stromal Cells
25%
Small Extracellular Vesicles
25%
Salmon Gelatin
24%
Pregnant Women
20%
Endometrial Stem Cells
20%
COVID-19
18%
T Helper 17 (Th17)
17%
Extracellular Vesicles
16%
Cell-based
16%
MicroRNA
16%
Mitochondria
15%
T Cells
15%
Ischemia-reperfusion Injury
14%
Cell Therapy
13%
Astrocytes
13%
During Pregnancy
13%
Voice Therapy
13%
Biomaterials
13%
Semi-occluded Vocal Tract Exercises (SOVTE)
13%
Fluoxetine
13%
Inducible Nitric Oxide Synthase
13%
First Trimester
12%
Macrophages
12%
Human Mesenchymal Stem Cells (hMSCs)
12%
Fetus
12%
Inflammation
12%
Gestational Diabetes Mellitus
12%
Placenta
11%
Water Resistance Therapy
11%
Maternal Plasma
11%
Chronic Kidney Disease
11%
Selective Intrauterine Growth Restriction (sIUGR)
11%
Chitosan-gelatin
11%
Vocal Fatigue
10%
Stem Cells
10%
Ischemia Injury
10%
Kidney
9%
Biopolymers
9%
Mitochondrial Transfer
9%
Therapeutic Properties
9%
Tissue Engineering
8%
Gelatin Film
8%
Vocal Tract
8%
Regulatory T (Treg) Cells
8%
Physiologic
8%
Voice Rehabilitation
8%
Hypoxia
8%
Experimental Autoimmune Encephalomyelitis
8%
Toll-like
8%
Quantitative PCR
8%
Bacterial Cellulose
8%
Interleukin-33 (IL-33)
8%
Female Fertility
8%
Dysphonia
8%
Neural Stem Cells
8%
Cell-derived
7%
Reperfusion
7%
Glassy State
7%
Vocal
7%
Chile
7%
Glycerol
7%
Angiogenesis
7%
Pregnancy Trimester
7%
Hippocampus
7%
Speech-language Pathologists
7%
Interleukin-17 (IL-17)
7%
Postsynaptic Density Protein 95 (PSD-95)
7%
Telepractice
7%
Stem Cell Therapy
7%
Ischemia
7%
Acute Respiratory Distress Syndrome
7%
Cell-mediated
7%
Stem Cell-derived
6%
Edible Film
6%
Regulatory T Cells
6%
Clinical Application
6%
Central Nervous System
6%
Gestational Diabetes
6%
Gestational Age
6%
Rat Model
6%
Endothelial Cells
6%
Nuclear Factor of Activated T-cells 5
6%
Oxidative Stress
6%
Menstrual Blood
6%
Neurogenesis
6%
Systemic Lupus Erythematosus
6%
Randomized Controlled Trial
6%
Placental Exosomes
6%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
6%
Peroxisome Proliferator-activated Receptor
6%
CD4+
6%
Directed Evolution
6%
Chilean
6%
Mesenchymal Stem Cell Therapy
6%
Preterm Birth
6%
Glass Transition Temperature
6%
Medicine and Dentistry
Mesenchymal Stem Cell
44%
Pre-Eclampsia
30%
Stem Cell
25%
Disease
24%
First Trimester Pregnancy
19%
Vocal Tract
16%
Exosome
14%
Gestational Diabetes
13%
Voice Therapy
13%
COVID-19
13%
Cell Therapy
12%
Ischemia
11%
Speech Production
10%
Mitochondrion
10%
Placenta
10%
Biological Marker
9%
In Vitro
9%
Therapy Resistance
8%
Intrauterine Growth Retardation
8%
Neonatal Infant
8%
Stromal Cell
8%
Dysphonia
8%
Female Fertility
8%
Messenger RNA
7%
Premature Labor
7%
Peritoneal Dialysis
7%
Pregnancy
7%
microRNA
7%
Randomized Controlled Trial
7%
Trophoblast
7%
Phonation
7%
Acute Kidney Injury
6%
Infection
6%
Chronic Kidney Disease
6%
Secretion (Process)
6%
Fetus Growth
6%
Gestational Age
6%
Reperfusion Injury
6%
Systemic Lupus Erythematosus
6%
Angiogenesis
6%
Fibroblast Growth Factor 23
6%
Speech Rehabilitation
6%
Ovarian Cancer
6%
Meta-Analysis
6%
Pathologist
5%
Hypoxia
5%
Programmed Cell Death
5%
Umbilical Cord
5%
Oxidative Stress
5%
Injury
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Telepractice
5%
Uterine Artery
5%
Vocal Folds
5%
Hemolytic Anemia
5%
Maternal Plasma
5%
Neutrophil Gelatinase Associated Lipocalin
5%